Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PRF1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PRF1 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic affects the expression of PRF1 mRNA | affects expression | 18414638
|
D001374 |
Azacitidine |
Azacitidine inhibits the reaction [IL2 protein results in increased secretion of PRF1 protein] | decreases reaction|increases secretion | 19394699
|
D000431 |
Ethanol |
Ethanol inhibits the reaction [IL2 protein results in increased expression of PRF1 mRNA] | decreases reaction|increases expression | 12700414
|
D005620 |
Freund's Adjuvant |
[Urethane co-treated with Freund's Adjuvant] results in decreased expression of PRF1 mRNA | affects cotreatment|decreases expression | 12400877
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of PRF1 mRNA | decreases expression | 20145137
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of PRF1 protein | decreases expression | 20145137
|
C070081 |
fulvestrant |
[fulvestrant results in increased expression of TGFB1 protein] which results in increased expression of PRF1 mRNA | increases expression | 20145137
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid inhibits the reaction [IL2 protein results in increased expression of PRF1 mRNA] | decreases reaction|increases expression | 12700414
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of PRF1 mRNA | decreases expression | 20145137
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of PRF1 protein | decreases expression | 20145137
|
D013629 |
Tamoxifen |
[Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of PRF1 mRNA | increases expression | 20145137
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of PRF1 mRNA | affects expression | 17440010
|
D013792 |
Thalidomide |
Thalidomide results in increased expression of PRF1 | increases expression | 17089043
|
D014107 |
Tosyllysine Chloromethyl Ketone |
Tosyllysine Chloromethyl Ketone inhibits the reaction [IL2 protein results in increased expression of PRF1 mRNA] | decreases reaction|increases expression | 12700414
|
D014107 |
Tosyllysine Chloromethyl Ketone |
Tosyllysine Chloromethyl Ketone results in decreased expression of PRF1 mRNA | decreases expression | 11266287
|
D014520 |
Urethane |
[Urethane co-treated with Freund's Adjuvant] results in decreased expression of PRF1 mRNA | affects cotreatment|decreases expression | 12400877
|
D014520 |
Urethane |
Urethane results in decreased expression of PRF1 mRNA | decreases expression | 12400877
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.68 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
9.49 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
9.49 | 8333272 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
10.87 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
10.87 | 11192467 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
3.34 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.84 | 15814487 |
MESH:D000236 |
Adenoma |
|
Urethane |
4.04 | 10822126 16926031 6695378 11497255 17093202 10530776 17195641 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.35 | 17306315 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.45 | 15451039 15451040 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.40 | 16510725 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.92 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
4.07 | 11141031 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.89 | 16251483 16835338 18414634 12569548 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
4.27 | 9598899 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.29 | 19371607 12928151 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.94 | 11514358 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18762240 |
MESH:D001862 |
Bone Resorption |
|
Freund's Adjuvant |
5.21 | 16769263 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.47 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.47 | 19189210 20390343 20135344 20544844 19059307 15565566 18629630 17242785 19011961 19410462 18815881 17261762 16273361 19200415 19142967 18821012 19221464 18997820 17893378 16873071 18855134 19289846 19244106 17440819 19189212 15668708 16202921 19103187 11161223 16818667 19155303 19115204 19084267 18425577 18351453 19066611 19288272 19487384 20065188 21138602 18984771 20859285 20005174 17049068 21152245 |
MESH:D002056 |
Burns |
|
Ethanol |
4.76 | 16374292 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.63 | 17687452 15504454 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.61 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.04 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
9.04 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
9.04 | 15763234 15289165 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
9.04 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
9.04 | 16313753 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
2.71 | 18922899 15504454 17687452 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
9.76 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.76 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
3.48 | 19332462 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.50 | 19152805 15738583 17938729 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.38 | 18022660 16973168 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.82 | 6135515 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
4.94 | 18291259 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.62 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
6.67 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
6.67 | 12810352 |
MESH:D003092 |
Colitis |
|
Thalidomide |
4.95 | 16680017 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.72 | 19934284 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.68 | 9301478 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
6.44 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
3.28 | 10194807 15451039 11873399 11198716 19302082 15513904 15451040 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
3.28 | 9200351 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
4.20 | 16078585 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.12 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.47 | 19031437 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.55 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.16 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
4.16 | 11566570 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.63 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.10 | 20544844 17893378 19155303 16202921 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.77 | 16704527 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
8.30 | 19236843 16409862 18620774 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.30 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.80 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.28 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.42 | 10194807 15451040 16946407 15513904 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.64 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.30 | 19069698 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.69 | 6392382 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.83 | 15046732 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
6.44 | 12701121 |
MESH:D005910 |
Glioma |
|
Thalidomide |
3.84 | 16327979 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
4.29 | 16046796 |
MESH:C537250 |
Hemophagocytic lymphohistiocytosis, familial, 2 |
marker/mechanism |
|
| |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.88 | 17440010 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
8.75 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Freund's Adjuvant |
8.75 | 16769263 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.53 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
2.90 | 9931084 16076760 11953799 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.69 | 16093927 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
3.80 | 11514358 |
MESH:D007249 |
Inflammation |
|
Freund's Adjuvant |
8.94 | 16793879 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.94 | 19457130 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
8.94 | 16134734 |
MESH:D007251 |
Influenza, Human |
|
pyrrolidine dithiocarbamic acid |
5.69 | 18473937 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
4.49 | 15513904 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.11 | 16930632 12749816 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.61 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.61 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
4.31 | 15451040 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
4.40 | 16514283 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
3.73 | 19148494 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.70 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
4.66 | 18720364 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
4.66 | 18720364 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.28 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.60 | 17339181 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
8.93 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
8.93 | 10473037 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.21 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
7.40 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
7.40 | 16943688 17174718 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
5.21 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
5.20 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pyrrolidine dithiocarbamic acid |
5.20 | 15078482 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
5.20 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
5.20 | 15465738 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.56 | 11134558 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.76 | 17207112 17347304 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.03 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
11.03 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
11.03 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
11.03 | 17559639 16391232 17093202 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.59 | 2876786 2876784 6135515 |
MESH:D055370 |
Lung Injury |
|
pyrrolidine dithiocarbamic acid |
5.09 | 16129981 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
5.05 | 17306315 17976673 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
5.05 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
5.05 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
5.05 | 17093202 12957351 16788158 16289808 11552296 11893704 12765245 11497255 11062179 6695378 14587096 16926031 11307925 11323394 17195641 10822126 12117781 12466968 11246140 16204055 15136453 15902970 7750092 11807781 10530776 10997738 16007126 17255336 16391232 16337739 11074608 10779650 11992545 11544531 15166089 |
OMIM:605027 |
LYMPHOMA, NON-HODGKIN, FAMILIAL |
marker/mechanism |
|
| |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.88 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.67 | 14580682 16827153 11731420 19196722 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.68 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.75 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
3.75 | 12829675 16098027 17089043 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.30 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
4.28 | 15451040 18411066 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.22 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
8.20 | 19549372 18443271 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
8.20 | 15741222 19112201 19372569 19112817 15867202 17168659 15744524 16445831 15920492 15939924 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
8.28 | 19805378 17611569 17596541 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
8.28 | 18720364 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.05 | 15371236 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.98 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.57 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.54 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Urethane |
3.54 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
4.78 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.13 | 19200415 19189210 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
5.02 | 16859833 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.50 | 16620997 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.46 | 17056641 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.51 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
8.38 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
8.38 | 16288038 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
8.38 | 16391232 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.99 | 12384795 |
MESH:D010291 |
Paresis |
|
Thalidomide |
6.44 | 9200351 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.27 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.11 | 6392382 15371236 16905509 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
5.52 | 16391232 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
4.27 | 17031469 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
1.92 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
1.92 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
pyrrolidine dithiocarbamic acid |
1.92 | 16139439 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.92 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
1.92 | 16729912 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.09 | 21343184 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
6.44 | 12755975 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
pyrrolidine dithiocarbamic acid |
5.08 | 16129981 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
6.06 | 16096327 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.28 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
6.28 | 9754883 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.76 | 16702368 19834688 6392382 18709164 17050553 15952646 16759981 17453740 17938729 16353154 17548696 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
6.44 | 16251483 17050553 17029826 17976673 19538983 15504454 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
6.44 | 11807781 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.43 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.15 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.30 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
8.07 | 16755016 9562338 11906479 17189318 17918041 9211565 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
8.07 | 15138204 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.33 | 9754883 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.53 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.53 | 17976673 17306315 19322015 18640142 11144890 19429237 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.53 | 17572228 8653321 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.43 | 10091137 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
12.63 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
12.63 | 15741222 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
6.05 | 10620525 |